Lapuerta Pablo
Insider CIK 1516368 · LXRX SVP, Clin Dev and CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2020-04-22 | 2020-04-24 | 19,893 | — | $0 | 92,532 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-04-22 | 2020-04-24 | 6,813 | $1.96 | $13.4K | 85,719 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 23,463 | — | $0 | 46,927 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 8,570 | — | $0 | 8,570 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 2,585 | — | $0 | 2,585 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-02-28 | 2020-03-03 | 4,228 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2020-02-28 | 2020-03-03 | 13,305 | $2.77 | $36.9K | 72,639 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 23,463 | — | $0 | 85,944 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 8,570 | — | $0 | 62,481 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 2,585 | — | $0 | 53,911 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-02-28 | 2020-03-03 | 4,228 | — | $0 | 51,326 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 247,220 | — | $0 | 247,220 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-02-06 | 2020-02-10 | 82,410 | — | $0 | 82,410 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 4,227 | — | $0 | 4,228 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 8,570 | — | $0 | 17,140 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 2,585 | — | $0 | 5,170 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2019-02-28 | 2019-03-01 | 4,550 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 2,585 | — | $0 | 45,337 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 4,227 | — | $0 | 42,752 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 4,550 | — | $0 | 38,525 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-01 | 6,809 | $5.51 | $37.5K | 47,098 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2019-02-28 | 2019-03-01 | 8,570 | — | $0 | 53,907 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 130,710 | — | $0 | 130,710 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-02-07 | 2019-02-08 | 70,390 | — | $0 | 70,390 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 4,550 | — | $0 | 4,550 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 4,228 | — | $0 | 8,455 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,585 | — | $0 | 7,755 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2018-02-28 | 2018-03-02 | 2,821 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,821 | — | $0 | 27,434 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 4,228 | — | $0 | 36,212 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 2,585 | — | $0 | 38,797 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2018-02-28 | 2018-03-02 | 4,822 | $8.53 | $41.1K | 33,975 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2018-02-28 | 2018-03-02 | 4,550 | — | $0 | 31,984 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 72,330 | — | $0 | 72,330 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-02-08 | 2018-02-12 | 25,710 | — | $0 | 25,710 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,822 | — | $0 | 2,821 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 4,227 | — | $0 | 12,683 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 4,550 | — | $0 | 9,100 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2017-02-28 | 2017-03-01 | 2,500 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,500 | — | $0 | 18,266 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 2,822 | — | $0 | 21,088 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 4,550 | — | $0 | 25,638 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2017-02-28 | 2017-03-01 | 4,227 | — | $0 | 29,865 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2017-02-28 | 2017-03-01 | 5,252 | $16.45 | $86.4K | 24,613 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 10,340 | — | $0 | 10,340 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-02-09 | 2017-02-13 | 41,370 | — | $0 | 41,370 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,500 | — | $0 | 2,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 1,857 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 2,821 | — | $0 | 5,643 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2016-02-29 | 2016-03-02 | 4,550 | — | $0 | 13,650 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,821 | — | $0 | 15,573 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 4,550 | — | $0 | 20,123 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2016-02-29 | 2016-03-02 | 4,357 | $9.07 | $39.5K | 15,766 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 2,500 | — | $0 | 12,752 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2016-02-29 | 2016-03-02 | 1,857 | — | $0 | 10,252 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 16,910 | — | $0 | 16,910 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-02-11 | 2016-02-16 | 67,640 | — | $0 | 67,640 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 17,500 | — | $0 | 35,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 13,000 | — | $0 | 13,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2015-03-02 | 2015-03-03 | 19,750 | — | $0 | 59,250 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 13,000 | — | $0 | 39,783 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 17,500 | — | $0 | 57,283 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2015-03-02 | 2015-03-03 | 19,750 | — | $0 | 77,033 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2015-03-02 | 2015-03-03 | 18,266 | $0.94 | $17.2K | 58,767 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 127,400 | — | $0 | 127,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-02-05 | 2015-02-09 | 509,600 | — | $0 | 509,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 17,500 | — | $0 | 52,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2014-02-28 | 2014-03-03 | 13,000 | — | $0 | 26,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2014-02-28 | 2014-03-03 | 11,992 | $1.92 | $23.0K | 26,783 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 13,000 | — | $0 | 21,275 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2014-02-28 | 2014-03-03 | 17,500 | — | $0 | 38,775 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 79,000 | — | $0 | 79,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-02-06 | 2014-02-10 | 316,000 | — | $0 | 316,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2013-02-28 | 2013-03-01 | 13,000 | — | $0 | 39,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2013-02-28 | 2013-03-01 | 13,000 | — | $0 | 13,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2013-02-28 | 2013-03-01 | 4,725 | $1.98 | $9.4K | 8,275 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 280,000 | — | $0 | 280,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-02-08 | 2013-02-12 | 70,000 | — | $0 | 70,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 52,000 | — | $0 | 52,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-02-15 | 2012-02-17 | 208,000 | — | $0 | 208,000 | SEC↗ |